D-Wave Quantum Is Down 15% This Year. Is Now the Time to Buy?

D-Wave reported 2025 revenue up 179% and gross profit up 265%, while ending the year with a record cash and liquidity position of more than $884 million. Bookings surged 471% in 2025 and topped $32 million in Q1 2026, nearly $8 million above last year's total revenue, but the company still posted a $355 million net loss and trades at an EV/revenue multiple near 280. The article frames the recent share-price dip as a potential entry point, though the stock remains highly speculative.

Analysis

QBTS is behaving less like a software story and more like a financing-controlled call option on quantum commercialization. The key second-order read is that the balance sheet gives management runway to keep converting headline bookings into hardware deployments without an immediate equity raise, which supports the multiple in the near term. But that same cash hoard can also mask how far away true unit economics are; the market is paying today for a business model that may not need to prove profitability for several quarters, yet any slowdown in bookings growth will compress the stock violently because the valuation already discounts a very long duration.

The competitive implication is not just about QBTS versus legacy chipmakers; it is about whether quantum remains a niche budget line or becomes a strategic capex category for large enterprises and governments. If bookings are being pulled forward by pilot programs, the next leg higher depends on conversion into recurring revenue and larger contract sizes, not simply more customer logos. That creates a timing asymmetry: sentiment can stay hot for months on backlog optics, but the stock is vulnerable in the next 1-2 earnings prints if management cannot show implementation velocity.

NVDA is a subtle loser in the narrative sense only. The CEO’s public framing is an attempt to re-rate quantum as a near-term substitute threat, but the more likely second-order effect is that it provokes investors to over-assign strategic importance to QBTS while ignoring the long adoption curve. That can create short squeezes in QBTS, but it does not materially impair NVDA’s core AI capex thesis over the next 12-24 months; if anything, it may briefly distract from the more durable GPU spending cycle.

The contrarian view is that the stock may be expensive even by hypergrowth standards because the market is capitalizing bookings like revenue quality before durability is established. The smartest trade is to express bullishness with defined risk rather than cash equity, since a single miss in bookings conversion or a cooldown in speculative flows could cut the stock dramatically despite the strong balance sheet. The article’s tone is bullish, but the real edge is in exploiting the gap between narrative momentum and business maturity.

Key Decisions for Investors

• Buy QBTS call spreads into the next earnings date rather than common stock; target 6-10 week tenor to capture sentiment momentum while capping downside if bookings conversion disappoints.
• Pair trade: long QBTS / short NVDA small size as a relative-value momentum trade only if quantum headlines continue to accelerate; size tightly because NVDA remains the higher-quality balance sheet compounder over 12-24 months.
• If already long QBTS, hedge with put spreads 15-20% below spot for the next 1-2 quarters; the setup is vulnerable to any guidance reset because valuation is already discounting aggressive commercialization.
• Avoid chasing common stock after a sharp green-day reversal; prefer entry only on 10-15% pullbacks when speculative flow cools, since the risk/reward is poor when enterprise-value-to-revenue remains extreme.
• For longer-duration exposure, wait for evidence that bookings are converting into revenue at a sustained cadence before adding size; until then, treat QBTS as a tactical trade, not a core fundamental long.